Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Aptiom

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 600Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupin Launches Eslicarbazepine Acetate Tablets in Us
    Lupin Launches Eslicarbazepine Acetate Tablets in Us

    08 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/lupin-launches-eslicarbazepine-acetate-tablets-in-us-17127

    INDPHARMAPOST
    08 May 2025
    Share Share
    Lupin's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Lupin's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    27 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211246

    FDA
    27 Mar 2024
    Share Share
    Hetero's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Hetero's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    03 Aug 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211186

    FDA
    03 Aug 2023
    Share Share
    Alkem's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Alkem's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    07 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211199

    FDA
    07 Dec 2022
    Share Share
    Aurobindo's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
    Aurobindo's Generic Eslicarbazepine Acetate Receives Approval in the U.S.

    21 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216481

    FDA
    21 Oct 2022
    Share Share
    Sph Shanghai Zhongxi Pharma's Generic Eslicarbazepine Acetate Receives Approval in US
    Sph Shanghai Zhongxi Pharma's Generic Eslicarbazepine Acetate Receives Approval in US

    22 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211247

    FDA
    22 Sep 2021
    Share Share